PNT - POINT Biopharma Global - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

POINT Biopharma Global's activity chart (see below) currently has 2 price targets and 1 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 59.67 days.

Most recent stock forecast was given by from CFRA on 22-Oct-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Oct-2024

$105

$105 (0.00%)

1 years 11 months ago
(22-Oct-2024)

0/1 (0%)

$105 (0.00%)

Hold Since 21-Dec-2023

$12.5

$27

2 years 9 months 2 days ago
(21-Dec-2023)

1/3 (33.33%)

$0.03 (0.24%)

5

Buy Since 26-Jul-2021

$12.5

$17

2 years 10 months 30 days ago
(24-Oct-2023)

1/3 (33.33%)

$-0.16 (-1.26%)

55

Buy Since 14-Dec-2022

$13

2 years 11 months 17 days ago
(06-Oct-2023)

2/2 (100%)

$3.73 (40.24%)

156

Hold

$22

2 years 11 months 18 days ago
(04-Oct-2023)

0/1 (0%)

$13.49 (158.52%)

Show more analysts

Please expand the browser size to see the chart

What is PNT (POINT Biopharma Global) average time for price targets to be met?

On average it took 60 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on PNT (POINT Biopharma Global)?

Which analyst has the most public recommendations on PNT (POINT Biopharma Global)?

has 0 price targets and 0 ratings on PNT

Which analyst is the currently most bullish on PNT (POINT Biopharma Global)?

Jonathan Sakraida with the highest potential upside of $105

Which analyst is the currently most reserved on PNT (POINT Biopharma Global)?

Edward Tenthoff with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?